Home Outcomes of children with severe diabetic ketoacidosis managed outside of a pediatric intensive care unit
Article
Licensed
Unlicensed Requires Authentication

Outcomes of children with severe diabetic ketoacidosis managed outside of a pediatric intensive care unit

  • Zoe T. Raleigh ORCID logo EMAIL logo , Zachary A. Drapkin , Dania M. Al-Hamad , Krishnamallika Mutyala , Jasmine R. Masih and Vandana S. Raman
Published/Copyright: December 6, 2022

Abstract

Objectives

Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes. Our objective was to determine if children with severe DKA without alteration in mental status can be managed safely on a general children’s medical unit.

Methods

Single center retrospective study of 191 patient encounters among 168 children admitted to the children’s medical unit (CMU) at Primary Children’s Hospital between 2007 and 2017 with severe DKA (pH <7.1 and/or bicarbonate <5 mmol/L). Chart review identified complications including death, transfer to the intensive care unit (ICU), incidence of cerebral edema, and hypoglycemia. We compared patients requiring ICU transfer with those who did not with respect to demographics, laboratory findings at presentation, therapeutic interventions, length of stay, and cost.

Results

Of 191 patient encounters, there were 0 deaths (0%, 95% CI 0–2.4%), 22 episodes of alteration of mental status concerning for developing cerebral edema (11.5%, 95% CI 7.7–16.9%), 19 ICU transfers (10%, 95% CI 6.4–15.1%), and 7 episodes of hypoglycemia (3.7%, 95% CI 1.6–7.5%). ICU transfer was associated lower initial pH (7.03 ± 0.06 vs. 7.07 ± 0.07, p<0.05), increased length of stay (3.0 ± 0.8 vs. 2.2 ± 0.9 days, p<0.05), and increased cost of hospitalization (mean ± SD $8,073 ± 2,042 vs. $5,217 ± 1,697, p<0.05).

Conclusions

The majority of children with severe DKA without alteration in mental status can be managed safely on a medical unit. Implementing a pH cutoff may identify high-risk patients that require ICU level of care.


Corresponding author: Zoe T. Raleigh, MD, Division of Endocrinology, Department of Pediatrics, University of Utah, 81 Mario Capecchi Drive, Salt Lake City, UT, 84113, USA, Phone: 801 213 7767, Fax: 801 213 7766, E-mail:

Acknowledgments

The authors thank the research staff and the division of pediatric endocrinology at Primary Children’s Hospital for help with data acquisition.

  1. Research funding: None declared.

  2. Author contributions: Z.R. conducted the literature review, chart review, and drafted the manuscript. Z.D. assisted with the literature review, performed the data analysis, and drafted the manuscript. V.R. oversaw study design and edited the manuscript. D.A., K.M. assisted with the chart review. J.M. assisted in drafting manuscript and assisted in submission of the manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: This study was approved by the University of Utah and Primary Children’s Institutional Review Board.

References

1. Scibilia, J, Finegold, D, Dorman, J, Becker, D, Drash, A. Why do children with diabetes die? Eur J Endocrinol 1986;113:S326–33. https://doi.org/10.1530/acta.0.112S326.Search in Google Scholar

2. Edge, JA, Ford-Adams, ME, Dunger, DB. Causes of death in children with insulin dependent diabetes 1990–96. Arch Dis Child 1999;81:318–23. https://doi.org/10.1136/adc.81.4.318.Search in Google Scholar PubMed PubMed Central

3. McNally, PG, Hearnshaw, JR, Raymond, NT, Botha, JL, Burden, ML, Burden, AC, et al.. Trends in mortality of childhood-onset insulin-dependent diabetes mellitus in leicestershire: 1940-1991. Diabet Med 1995;12:961–6. https://doi.org/10.1111/j.1464-5491.1995.tb00406.x.Search in Google Scholar PubMed

4. Muir, AB, Quisling, RG, Yang, MCK, Rosenbloom, AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care 2004;27:1541–6. https://doi.org/10.2337/diacare.27.7.1541.Search in Google Scholar PubMed

5. Rosenbloom, AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990;13:22–33. https://doi.org/10.2337/diacare.13.1.22.Search in Google Scholar PubMed

6. Glaser, N, Barnett, P, McCaslin, I, Nelson, D, Trainor, J, Louie, J, et al.. Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 2001;344:264–9. https://doi.org/10.1056/nejm200101253440404.Search in Google Scholar

7. Lawrence, SE. Diagnosis and treatment of diabetic ketoacidosis in children and adolescents. Paediatr Child Health 2005;10:21–4.Search in Google Scholar

8. Wolfsdorf, J, Glaser, N, Sperling, MA. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care 2006;29:1150–9. https://doi.org/10.2337/dc06-9909.Search in Google Scholar

9. Wolfsdorf, JI, Glaser, N, Agus, M, Fritsch, M, Hanas, R, Rewers, A, et al.. Diabetic ketoacidosis and hyperglycemic hyperosmolar state: a consensus statement from the international society for pediatric and adolescent diabetes. Pediatr Diabetes 2018;19:155–77.10.1111/pedi.12701Search in Google Scholar PubMed

10. Chase, HP, Garg, SK, Jelley, DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev 1990;11:297. https://doi.org/10.1542/pir.11.10.297.Search in Google Scholar

11. Andrade‐Castellanos, CA, Colunga‐Lozano, LE, Delgado‐Figueroa, N, Gonzalez‐Padilla, DA. Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis. Cochrane Libr 2016;2016:CD011281.10.1002/14651858.CD011281Search in Google Scholar

12. Savoldelli, RD, Farhat, SCL, Manna, TD. Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department. Diabetol Metab Syndrome 2010;2:41. https://doi.org/10.1186/1758-5996-2-41.Search in Google Scholar PubMed PubMed Central

13. Della Manna, T, Steinmetz, L, Campos, PR, Farhat, SCL, Schvartsman, C, Kuperman, H, et al.. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care 2005;28:1856–61. https://doi.org/10.2337/diacare.28.8.1856.Search in Google Scholar PubMed

14. Cohen, M, Leibovitz, N, Shilo, S, Zuckerman‐Levin, N, Shavit, I, Shehadeh, N. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Pediatr Diabetes 2017;18:290–6. https://doi.org/10.1111/pedi.12380.Search in Google Scholar PubMed

15. Lawrence, SE, Cummings, EA, Gaboury, I, Daneman, D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr 2005;146:688–92. https://doi.org/10.1016/j.jpeds.2004.12.041.Search in Google Scholar PubMed

16. Edge, JA, Jakes, RW, Roy, Y, Hawkins, M, Winter, D, Ford-Adams, ME, et al.. The UK case–control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006;49:2002–9. https://doi.org/10.1007/s00125-006-0363-8.Search in Google Scholar PubMed

17. Seattle, Children’s. Cerebral Edema Diabetic Ketoacidosis (DKA) [Internet]. 2017. Available from: https://www.seattlechildrens.org/pdf/DKA-pathway.pdf [Accessed 4 May 2019].Search in Google Scholar

18. Diabetes Type 1, with DKA Clinical Pathway — Emergency. Children’s Hospital of Philadelphia [Internet]. 2006. Available from: https://www.chop.edu/clinical-pathway/diabetes-type1-with-dka-clinical-pathway [Accessed 4 May 2019].Search in Google Scholar

19. DKA Treatment Protocol Barbara Davis for Childhood Diabetes, University of Colorado & Children’s Hospital Colorado [Internet]. 2018. Available from: https://www.ucdenver.edu/docs/librariesprovider48/patient-provider-resources/bdc-dka-treatment-protocol-2018-194a783be5302864d9a5bfff0a001ce385.pdf?sfvrsn=8b505fb9_2 [Accessed 4 May 2019].Search in Google Scholar

20. Harriet Lane Service (Johns Hopkins Hospital), Hughes, HK, Kahl, L. The Harriet Lane handbook: a manual for pediatric house officers. Amsterdam: Elseiver.Search in Google Scholar

21. Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 2009;42:377–81. https://doi.org/10.1016/j.jbi.2008.08.010.Search in Google Scholar PubMed PubMed Central

22. Kuppermann, N, Ghetti, S, Schunk, JE, Stoner, MJ, Rewers, A, McManemy, JK, et al.. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med 2018;378:2275–87.10.1056/NEJMoa1716816Search in Google Scholar PubMed PubMed Central

23. Edge, JA, Hawkins, MM, Winter, DL, Dunger, DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 2001;85:16–22. https://doi.org/10.1136/adc.85.1.16.Search in Google Scholar PubMed PubMed Central


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2022-0457).


Received: 2022-09-12
Accepted: 2022-11-11
Published Online: 2022-12-06
Published in Print: 2023-02-23

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. One half-century of advances in the evaluation and management of disorders of bone and mineral metabolism in children and adolescents
  4. Original Articles
  5. Safety and user experience with off-label use of a flash glucose monitor (FreeStyle Libre® 1) among very young children with type 1 diabetes mellitus
  6. Sonic hedgehog N-terminal level correlates with adiponectin level and insulin resistance in adolescents
  7. Elevated amylase and lipase levels in patients with DKA followed in the pediatric intensive care unit
  8. The relationship between alexithymia, health literacy, and diet quality in obese adolescents
  9. The role of the deficiency of vitamin B12 and folic acid on homocysteinemia in children with Turner syndrome
  10. Clinical spectrum and diagnostic challenges of vitamin D dependent rickets type 1A (VDDR1A) caused by CYP27B1 mutation in resource limited countries
  11. Comparative characteristics of developing morphofunctional features of schoolchildren from different climatic and geographical regions
  12. Leucine tolerance in children with MSUD is not correlated with plasma leucine levels at diagnosis
  13. Outcomes of children with severe diabetic ketoacidosis managed outside of a pediatric intensive care unit
  14. Thiamine status during treatment of diabetic ketoacidosis in children – tertiary care centre experience
  15. Premature adrenarche in Prader–Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age
  16. Short Communication
  17. Diagnosis of adrenal insufficiency in children: a survey among pediatric endocrinologists in North America
  18. Case Reports
  19. Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance
  20. Two cases of MEGDHEL syndrome diagnosed with hyperammonemia
  21. Hyperinsulinism–hyperammonemia syndrome in two Peruvian children with refractory epilepsy
  22. A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism
  23. Adolescents with type 1 diabetes vs. hybrid closed loop systems: a case series of patients’ behaviour that challenges the algorithm.
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0457/html
Scroll to top button